Bionure
Manufacturing · Spain · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Carrer De Sant Joan De Malta 145 local 1...Phone Number
+34 931258607Website
www.bionure.comRevenue
<$5 MillionIndustry
About Bionure
Is Bionure your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Bionure launches new products
Funding: Get notified immidiatlly once Bionure has new funding data
Website visits: Recent activity has been detected on your website
Check out if Bionure is spiking on competitors!
Earning: See what the market has to say on Bionure recently announced quarterly report
Bionure, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Bionure
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Bionure had a recent Job posting/layoffs
Check if Bionure has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Bionure is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Bionure is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Bionure.
Bionure Tech Stack
A closer look at the technologies used by Bionure
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bionure
Bionure is focused on developing innovative therapies for neurodegenerative diseases, utilizing therapeutic RNA to combat conditions such as ALS, Rett syndrome, ataxia, and Huntington's disease. Founded in 2009, the company aims to prevent brain damage and slow the progression of neurological disorders. In 2023, Bionure Therapeutics shifted its str... Read More